Jenburkt Pharmaceuticals

quarterly
yearly
ParticularsSep '22Dec '22Mar '23Jun '23Sep '23
Revenue37.1136.0336.4630.2239.39
Expenses27.8728.2728.3822.7829.85
EBITDA9.878.448.758.0010.20
EBIT9.337.868.167.509.61
Profit Before Tax9.247.758.077.439.54
Net Profit6.875.436.355.377.32
Financial Ratios
Operating Profit Margin27.56%24.41%24.86%27.42%26.64%
Net Profit Margin19.16%15.71%18.04%18.40%19.12%
Earning Per Share (Diluted)14.9611.8413.9212.1716.59
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.5.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ